Puma Biotechnology Earnings Call March 2023 | NERLYNX Commercial Update

Puma Biotechnology's March 2023 earnings call presentation providing a commercial update on NERLYNX and the company's drug development pipeline. The document outlines the company's pharmacy and distributor network strategy for patient care delivery across academic hospitals, community hospitals, and physician practices.